Cite

HARVARD Citation

    Spadafora, L. et al. (2022). Imatinib as a Tool Against COVID-19: A Balancing Act Between Effectiveness and Cardiac Safety. Journal of cardiovascular pharmacology. 80 (6), pp. 779-780. [Online]. 
  
Back to record